Height, body mass index, and ovarian cancer: A follow-up of 1.1 million Norweigian women

Journal of the National Cancer Institute

Volumn 95, Issue 16, 2003, Pages 1244-1248

  Engeland, Anders ^a   Tretli, Steinar ^b   Bjørge, Tone ^c  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b CANCER REGISTRY OF NORWAY   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; NORWAY; OBESITY; OVARY CANCER; POPULATION RESEARCH; PRIORITY JOURNAL; MIDDLE AGED; OVARY TUMOR; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; ADULT; AGED; BODY HEIGHT; BODY MASS INDEX; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NORWAY; OBESITY; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS;

EID: 0041911331     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djg010     Document Type: Article

References (33)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-41.
2. Bjørge T, Engeland A, Hansen S, Trope CG. Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-1993. Int J Cancer 1997;71:780-6.
3. Farrow DC, Weiss NS, Lyon JL, Daling JR. Association of obesity and ovarian cancer in a case-control study. Am J Epidemiol 1989; 129:1300-4.
4. Purdie D, Green A, Bain C, Siskind V, Ward B, Hacker N, et al. Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group. Int J Cancer 1995;62:678-84.
5. Purdie DM, Bain CJ, Webb PM, Whiteman DC, Pirozzo S, Green AC. Body size and ovarian cancer: case-control study and systematic review (Australia). Cancer Causes Control 2001;12:855-63.
6. Lukanova A, Toniolo P, Lundin E, Micheli A, Akhmedkhanov A, Muti P, et al. Body mass index in relation to ovarian cancer: a multi-centre nested case-control study. Int J Cancer 2002;99:603-8.
7. Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM. Height, leg length, and cancer risk: a systematic review. Epidemiol Rev 2001;23:313-42.
8. Polychronopoulou A, Tzonou A, Hsieh CC, Kaprinis G, Rebelakos A, Toupadaki N, et al. Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer. Int J Cancer 1993;55:402-7.
9. Waaler HT. Height, weight and mortality. The Norwegian experience. Acta Med Scand Suppl 1984;679:1-56.
10. Bjartveit K, Foss OP, Gjervig T, Lund-Larsen PG. The cardiovascular disease study in Norwegian counties. Background and organization. Acta Med Scand Suppl 1979;634: 1-70.
11. Bjartveit K. The National Health Screening Service: From fight against tuberculosis to many-sided epidemiological activities. Nor Epidemiol 1997;7:157-74.
12. Tverdal A. Prevalence of obesity among persons aged 40-42 years in two periods. Tidsskr Nor Laegeforen 2001;121:667-72.
13. Engeland A, Bjørge T, Selmer RM, Tverdal A. Height and body mass index in relation to total mortality. Epidemiology 2003;14: 293-9.
14. Engeland A, Bjørge T, Søgaard AJ, Tverdal A. Body mass index in adolescence in relation to total mortality: 32-year follow-up of 227,000 Norwegian boys and girls. Am J Epidemiol 2003;157:517-23.
15. Tingulstad S, Halvorsen T, Norstein J, Hagen B, Skjeldestad FE. Completeness and accuracy of registration of ovarian cancer in the cancer registry of Norway. Int J Cancer 2002; 98:907-11.
16. The Cancer Registry of Norway. Cancer in Norway 2000. Oslo (Norway): The Cancer Registry of Norway; 2002. p. 1-91.
17. The Cancer Registry of Norway. April 2003. Available at: http://www.kreftregisteret.no/. [Last accessed: June 20, 2003.]
18. Cox DR, Oakes D. Analysis of survival data. London (U.K.): Chapman and Hall Ltd.; 1984. p. 1-201.
19. National Center for Health Statistics. CDC Growth Charts: August 2002. United States. Available at: http://www.cdc.gov/growthcharts/. [Last accessed: June 20, 2003.]
20. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, et al. CDC growth charts: United States. Adv Data 2000;314:1-27.
21. World Health Organization (WHO) Consultation on Obesity. Preventing and managing the global epidemic: Report of a WHO Consultation on Obesity, Geneva, 3-5 June 1997. Geneva (Switzerland): WHO; 1998. p. 1-276.
22. SPSS for Windows. Release 11.0.1. 2001.
23. Plankey MW, Stevens J, Flegal KM, Rust PF. Prediction equations do not eliminate systematic error in self-reported body mass index. Obes Res 1997;5:308-14.
24. Nawaz H, Chan W, Abdulrahman M, Larson D, Katz DL. Self-reported weight and height: implications for obesity research. Am J Prev Med 2001;20:294-8.
25. Kuczmarski MF, Kuczmarski RJ, Najjar M. Effects of age on validity of self-reported height, weight, and body mass index: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Am Diet Assoc 2001;101:28-34.
26. Rodriguez C, Calle EE, Fakhrabadi-Shokoohi D, Jacobs EJ, Thun MJ. Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2002;11:822-8.
27. Fairfield KM, Willett WC, Rosner BA, Manson JE, Speizer FE, Hankinson SE. Obesity, weight gain, and ovarian cancer. Obstet Gynecol 2002;100:288-96.
28. Graff-Iversen S, Stensvold I, Lund-Larsen PG, Nodarse LO, Tverdal A, Urdal P. Serum lipids in postmenopausal or perimenopausal women using estrogen alone, estrogen with levonorgestrel, or estrogen with norethisterone, compared with nonusers: results from a cross-sectional study in two Norwegian counties 1985-1988. J Clin Epidemiol 1998; 51:1311-6.
29. Bertone ER, Rosner BA, Hunter DJ, Stampfer MJ, Speizer FE, Colditz GA, et al. Dietary fat intake and ovarian cancer in a cohort of US women. Am J Epidemiol 2002;156: 22-31.
30. Lubin F, Chetrit A, Freedman LS, Alfandary E, Fishler Y, Nitzan H, et al. Body mass index at age 18 years and during adult life and ovarian cancer risk. Am J Epidemiol 2003; 157:113-20.
31. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 1998;90:1774-86.
32. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;136: 1212-20.
33. Schouten LJ, Goldbohm RA, van den Brandt PA. Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer. Am J Epidemiol 2003;157:424-33.